Cargando…

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C

Human killer cell immunoglobulin-like receptors (KIRs) are distinguished by expansion of activating KIR2DS, whose ligands and functions remain poorly understood. The oldest, most prevalent KIR2DS is KIR2DS4, which is represented by a variable balance between “full-length” and “deleted” forms. We fin...

Descripción completa

Detalles Bibliográficos
Autores principales: Graef, Thorsten, Moesta, Achim K., Norman, Paul J., Abi-Rached, Laurent, Vago, Luca, Older Aguilar, Anastazia M., Gleimer, Michael, Hammond, John A., Guethlein, Lisbeth A., Bushnell, David A., Robinson, Philip J., Parham, Peter
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768862/
https://www.ncbi.nlm.nih.gov/pubmed/19858347
http://dx.doi.org/10.1084/jem.20091010
_version_ 1782173524937408512
author Graef, Thorsten
Moesta, Achim K.
Norman, Paul J.
Abi-Rached, Laurent
Vago, Luca
Older Aguilar, Anastazia M.
Gleimer, Michael
Hammond, John A.
Guethlein, Lisbeth A.
Bushnell, David A.
Robinson, Philip J.
Parham, Peter
author_facet Graef, Thorsten
Moesta, Achim K.
Norman, Paul J.
Abi-Rached, Laurent
Vago, Luca
Older Aguilar, Anastazia M.
Gleimer, Michael
Hammond, John A.
Guethlein, Lisbeth A.
Bushnell, David A.
Robinson, Philip J.
Parham, Peter
author_sort Graef, Thorsten
collection PubMed
description Human killer cell immunoglobulin-like receptors (KIRs) are distinguished by expansion of activating KIR2DS, whose ligands and functions remain poorly understood. The oldest, most prevalent KIR2DS is KIR2DS4, which is represented by a variable balance between “full-length” and “deleted” forms. We find that full-length 2DS4 is a human histocompatibility leukocyte antigen (HLA) class I receptor that binds specifically to subsets of C1(+) and C2(+) HLA-C and to HLA-A*11, whereas deleted 2DS4 is nonfunctional. Activation of 2DS4(+) NKL cells was achieved with A*1102 as ligand, which differs from A*1101 by unique substitution of lysine 19 for glutamate, but not with A*1101 or HLA-C. Distinguishing KIR2DS4 from other KIR2DS is the proline–valine motif at positions 71–72, which is shared with KIR3DL2 and was introduced by gene conversion before separation of the human and chimpanzee lineages. Site-directed swap mutagenesis shows that these two residues are largely responsible for the unique HLA class I specificity of KIR2DS4. Determination of the crystallographic structure of KIR2DS4 shows two major differences from KIR2DL: displacement of contact loop L2 and altered bonding potential because of the substitutions at positions 71 and 72. Correlation between the worldwide distributions of functional KIR2DS4 and HLA-A*11 points to the physiological importance of their mutual interaction.
format Text
id pubmed-2768862
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-27688622010-04-26 KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C Graef, Thorsten Moesta, Achim K. Norman, Paul J. Abi-Rached, Laurent Vago, Luca Older Aguilar, Anastazia M. Gleimer, Michael Hammond, John A. Guethlein, Lisbeth A. Bushnell, David A. Robinson, Philip J. Parham, Peter J Exp Med Article Human killer cell immunoglobulin-like receptors (KIRs) are distinguished by expansion of activating KIR2DS, whose ligands and functions remain poorly understood. The oldest, most prevalent KIR2DS is KIR2DS4, which is represented by a variable balance between “full-length” and “deleted” forms. We find that full-length 2DS4 is a human histocompatibility leukocyte antigen (HLA) class I receptor that binds specifically to subsets of C1(+) and C2(+) HLA-C and to HLA-A*11, whereas deleted 2DS4 is nonfunctional. Activation of 2DS4(+) NKL cells was achieved with A*1102 as ligand, which differs from A*1101 by unique substitution of lysine 19 for glutamate, but not with A*1101 or HLA-C. Distinguishing KIR2DS4 from other KIR2DS is the proline–valine motif at positions 71–72, which is shared with KIR3DL2 and was introduced by gene conversion before separation of the human and chimpanzee lineages. Site-directed swap mutagenesis shows that these two residues are largely responsible for the unique HLA class I specificity of KIR2DS4. Determination of the crystallographic structure of KIR2DS4 shows two major differences from KIR2DL: displacement of contact loop L2 and altered bonding potential because of the substitutions at positions 71 and 72. Correlation between the worldwide distributions of functional KIR2DS4 and HLA-A*11 points to the physiological importance of their mutual interaction. The Rockefeller University Press 2009-10-26 /pmc/articles/PMC2768862/ /pubmed/19858347 http://dx.doi.org/10.1084/jem.20091010 Text en © 2009 Graef et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Article
Graef, Thorsten
Moesta, Achim K.
Norman, Paul J.
Abi-Rached, Laurent
Vago, Luca
Older Aguilar, Anastazia M.
Gleimer, Michael
Hammond, John A.
Guethlein, Lisbeth A.
Bushnell, David A.
Robinson, Philip J.
Parham, Peter
KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
title KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
title_full KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
title_fullStr KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
title_full_unstemmed KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
title_short KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
title_sort kir2ds4 is a product of gene conversion with kir3dl2 that introduced specificity for hla-a(*)11 while diminishing avidity for hla-c
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768862/
https://www.ncbi.nlm.nih.gov/pubmed/19858347
http://dx.doi.org/10.1084/jem.20091010
work_keys_str_mv AT graefthorsten kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac
AT moestaachimk kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac
AT normanpaulj kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac
AT abirachedlaurent kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac
AT vagoluca kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac
AT olderaguilaranastaziam kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac
AT gleimermichael kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac
AT hammondjohna kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac
AT guethleinlisbetha kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac
AT bushnelldavida kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac
AT robinsonphilipj kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac
AT parhampeter kir2ds4isaproductofgeneconversionwithkir3dl2thatintroducedspecificityforhlaa11whilediminishingavidityforhlac